Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance

Blood Purification

Volumn 18, Issue 3, 2000, Pages 191-199

  Morena, Marion ^a   Cristol, Jean Paul ^a,b   Canaud, Bernard ^b  

^a Biochemistry Laboratory   (France)

^b LAPEYRONIE HOSPITAL   (France)

Author keywords

Antioxidant; Atherosclerosis; Hemodialysis; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; LIPOSOME; REACTIVE OXYGEN METABOLITE; SELENIUM;

AMYLOIDOSIS; ANEMIA; ATHEROSCLEROSIS; DIALYSATE; DIALYSIS MEMBRANE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UREMIA;

EID: 0033865908     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014418     Document Type: Review

References (60)

1. Lindner A, Charra B, Sherrard D, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Ross R: Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340: 115-126.
3. Crastes de Paulet A, Toreilles J, Cristol JP: Lipids as a preferential target for oxidative stress; in Paoletti R et al (eds): Oxidative Processes and Antioxidants. New York, Raven Press, 1994, pp 73-96.
4. Thiemermann C: NO and septic shock. Gen Pharmacol 1997;29:159-166.
5. Britigan BE, Edeker BL: Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J Clin Invest 1991;88:1092-1102.
6. Johnson KR, Nauseef WM: Molecular biology of MPO; in Everse J, Everse KE (eds): Peroxidases in Chemistry and Biology. Boca Raton, CRC Press. 1991, vol II, pp 63-81.
7. Lonnemann G, Linnenweber S, Burg M, Koch KM: Transfer of endogenous pyrogens across artificial membranes? Kidney Int Suppl 1998;66:S43-S46.
8. Hasselwander O, Young IS: Oxidative stress in chronic renal failure. Free Radic Res 1998;29:1-11.
9. Ward RA, McLeish KR: Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 1994;5: 1697-1702.
10. Ward RA, McLeish KR: Hemodialysis with cellulose membranes primes the neutrophil oxidative burst. Artif Organs 1995;19:801-807.
11. Cristol JP, Canaud B, Rabesandratana H, Gaillard I, Serre A, Mion C: Enhancement of reactive oxygen species production and cell surface markers expression during hemodialysis. Nephrol Dial Transplant 1994;9:389-394.
12. Chen MF, Chang CL, Liou SY: Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif 1998; 16:290-300.
13. DeLeo FR, Renee J, McCormick S, Nakamura M, Apicella M, Weiss JP: Neutrophils exposed to bacterial lipopolysaccharide upregulatc NADPH oxidase assembly. J Clin Invest 1998;101:455-463.
14. Dinarello CA, Lonnemann G, Bingel M, Koch KM, Shaldon S: Biological consequences of monocyte activation during hemodialysis. Contrib Nephrol. Basel, Karger, 1987, vol 59, pp 1-9.
15. Lonnemann G, Haubitz M, Schindler R: Hemodialysis-associated induction of cytokines. Blood Purif 1990;8:214-222.
16. Haubitz M, Kloppel B, Lonnemann G, Nonnast-Daniel B: In vitro production of interleukin-1 from blood mononuclear cells of patients on chronic hemodialysis therapy. Clin Nephrol 1992;38:30-35.
17. Knudsen PJ, Leon J, Ng AK, Shaldon S, Floege J, Koch KM: Hemodialysis-related induction of beta-2-microglobulin and interleukin-1 synthesis and release by mononuclear phagocytes. Nephron 1989; 53:188-193.
18. Knudsen PJ, Shaldon S, Floege J, Koch M: Hemodialysis-related induction of beta-2-microglobulin synthesis and release by mononuclear phagocytes. Int J Artif Organs 1990;13:73-76.
19. Kumano K, Yokota S, Nanbu M, Sakai T: Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes? Kidney Int 1993; 43(suppl 41):S205-S208.
20. Niwa Y, Ozaki Y, Kanoh T, Akamatsu H, Kurisaka M: Role of cytokines, tyrosine kinase, and protein kinase C on production of superoxide and induction of scavenging enzymes in human leukocytes. Clin Immunol Immunopathol 1996;79:303-313.
21. Serfilippi G, Ferro TJ, Johnson A: Activation of protein kinase C mediates altered pulmonary vasoreactivity induced by tumor necrosis factor-alpha. Am J Physiol 1994;267:L282-L290.
22. Nockher WA, Scherberich JE: Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: Evidence for chronic exposure to LPS. Kidney Int 1995;48:1469-1476.
23. Girelli D, Olivieri O, Stanzial AM, Azzini M, Lupo A, Bernich P, Menini C, Gammaro L, Corrocher R: Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: Relations to dialysis treatments, diet and cardiovascular complications. Clin Sci (Colch) 1993;84:611-617.
24. Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Nguyen AT, Thevenin M, Jaudon MC, Zingraff J, Verger C, Jungers P, Descamps-Latscha B: Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 1996;21:845-853.
25. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339: 572-575.
26. Arese M, Cristol JP, Bosc JY, Bussolino F, Wratten ML, Tetta C, Strasly M, Canaud B: Removal of constitutive and inducible nitric oxide synthase-active compounds in a modified hemodiafiltration with on-line production of substitution fluid: The contribution of convection and diffusion. Artif Kidney Dial 1996; 19:25-32.
27. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Descomps B, Canaud B: Convective and diffusive losses of vitamin C during hemodiafiltration session: A contributive factor to oxidative stress in hemodialysis patients. Nephrol Dial Transplant 1998;13:A200.
28. Koenig JS, Fischer M, Bulant E, Tiran B, Elmadfa I, Druml W: Antioxidant status in patients on chronic hemodialysis therapy: Impact of parenteral selenium supplementation. Wien Klin Wochenschr 1997;109:13-19.
29. Arese M, Strasly M, Ruva C, et al: Regulation of nitric oxide synthesis in uraemia. Nephrol Dial Transplant 1995;10: 1386-1397.
30. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER: Oxidative stress in haemodialysis. Q J Med 1994;87:679-683.
31. Paul JL, Sall ND, Soni T, Poignet JL, Lindenbaum A, Man NK, Moatti N, Raichvarg D: Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993;64:106-109.
32. Cristol JP, Maggi MF, Bosc JY, Badiou S, Delage M, Vernet MH, Michel F, Castel J, Canaud B, Descomps B: Oxidative stress and chronic renal insufficiency: What can be a prophylactic approach? C R Seances Soc Biol Fil 1997;191:603-616.
33. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49: 1304-1313.
34. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drucke T, Descamps-Latscha B: Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161:2524-2532.
35. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol. Modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915-924.
36. Esterbauer H, Gebicki J, Puhl H, Jürgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-390.
37. Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-416.
38. Ross R: Atherogenesis; in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press, 1992, pp 1051-1059.
39. Maggi E, Bellazzi R, Falaschi F, Frattoni A, Perani G, Finardi G, Gazo A, Nai M, Romanini D, Bellomo G: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int 1994;45:876-883.
40. Sutherland W, Walker R, Ball M, Stapley S, Robertson M: Oxidation of low density lipoproteins from patients with renal failure or renal transplants. Kidney Int 1995;48:227-236.
41. Loughrey CM, Young IS, Eneny J, McDowell IFW, McMaster C, McNamee PT, McTrimble ER: Oxidation of low density lipoprotein in patients on regular haemodialysis. Atherosclerosis 1994; 110:185-193.
42. Westhuyzen J, Saltissi D, Healy H: Oxidation of low density lipoprotein in hemodialysis patients: Effect of dialysis and comparison with matched controls. Atherosclerosis 1997;129:199-205.
43. Panzetta O, Cominacini L, Garbin U, Fratta Pasini A, Gammaro L, Bianco F, Davoli A, Campagnola M, De Santis A, Pastorino AM: Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: Effects of fish oil and vitamin E administration. Clin Nephrol 1995;44:303-309.
44. Morena M, Cristol JP, Dantoine T, Carbonneau MA, Descomps B, Canaud B: Protective effects of HDL against oxidative stress are impaired in hemodialysis patients. Nephrol Dial Transplant 2000; 15:389-395.
45. Ando Y, Suhr O, El-Salhy M: Oxidative stress and amyloidosis. Histol Histopathol 1998;3:845-850.
46. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, van Ypersele de Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997;51:1170-1181.
47. Rice-Evans C, Omorphos SC, Baysal E: Sickle cell membranes and oxidative damage. Biochem J 1986;237:265-269.
48. Flynn TP, Allen DW, Johnson GJ, White JG: Oxidant damage of the lipids and proteins of the erythrocyte membranes in unstable hemoglobin disease: Evidence for the role of lipid peroxidation? J Clin Invest 1983;71:1215-1223.
49. Jacob HJ, Eaton JW, Yawata NY: Shortened blood cell survival in uremic patients: Beneficial and deleterious effects of dialysis. Kidney Int 1975;7(suppl 2):139-143.
50. Eschbach JW: The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989;35:134-148.
51. Delmas-Beauvieux MC, Combe C, Peuchant E, Carbonneau MA, Dubourg L, de Périgout V, Aparicio M, Clerc M: Evaluation of red blood cell lipoperoxidation in haemodialyzed patients during erythropoietin therapy supplemented or not with iron. Nephron 1995;69:404-410.
52. Canaud B, Bosc JY, Leray H, Stec F, Argiles A, Leblanc M, Mion C: On-line haemodiafiltration: State of the art. Nephrol Dial Transplant 1998;5:3-11.
53. Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorrho R, Descomps B, Canaud B: Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997;12:2312-2317.
54. Bohm V, Tiroke K, Schneider S, Sperschneider H, Stein G, Bitsch R: Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. Int J Vitam Nutr Res 1997;67:262-266.
55. Hussein O, Rosenblat M, Refael G, Aviram M: Dietary selenium increases cellular glutathione peroxidase activity and reduces the enhanced susceptibility to lipid peroxidation of plasma and low-density lipoprotein in kidney transplant recipient. Transplantation 1997;63:679-685.
56. Buoncristiani U, Galli F, Rovidati S, Albertini MC, Campus G, Canestrari F: Oxidative damage during hemodialysis using a vitamin-E-modified dialysis membrane: A preliminary characterization. Nephron 1997;77:57-61.
57. Galli F, Rovidati S, Chiarantini L, Campus G, Canestrari F, Buoncristiani U: Bioreactivity and biocompatibility of a vitamin E-modified multilayer hemodialysis filter. Kidney Int 1998;54:580-589.
58. Wratten ML, Navino C, Tetta C, Verzetti G: Haemolipodialysis. Blood Purif 1999;17:127-133.
59. Sevanian A, Asatryan L, Ziouzenkova O: Low density lipoprotein modification: Basic concepts and relationship to atherosclerosis. Blood Purif 1999;17:66-78.
60. Tetta C, Wratten ML, Cristol JP, Tarchini R, Bosc JY, Canaud B, Camussi G: The role of platelet-activating factor in the haemocompatibility of haemodialytic treatments. Intern J Artif Organs 1998;21:693-698.